Answers are grounded in this paper and cite their sources.
Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed.
No takes yet. Share an insight, caveat, or question.
Elshimali et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: